Literature DB >> 23807152

Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.

Sara Leddy1, Shahrzad Hadavi, Andrew McCarren, Gavin Giovannoni, Ruth Dobson.   

Abstract

The Expanded Disability Status Scale (EDSS) is the current 'gold standard' for monitoring disease severity in multiple sclerosis (MS). The EDSS is a physician-based assessment. A patient-related surrogate for the EDSS may be useful in remotely capturing information. Eighty-one patients (EDSS range 0-8) having EDSS as part of clinical trials were recruited. All patients carried out the web-based survey with minimal assistance. Full EDSS scores were available for 78 patients. The EDSS scores were compared to those generated by the online survey using analysis of variance, matched pair test, Pearson's coefficient, weighted kappa coefficient, and the intra-class correlation coefficient. The internet-based EDSS scores showed good correlation with the physician-measured assessment (Pearson's coefficient = 0.85). Weighted kappa for full agreement was 0.647. Full agreement was observed in 20 patients who had EDSS scores ranging from 0 to 6; many of those with 100 % agreement had scores of 5.5-6 (n = 8).The intra-class coefficient was 0.844 overall for all cases. Internet-based FS and EDSS show good agreement with physician-measured scores. Agreement was better in patients with higher scores. Overall patient satisfaction with the web-based assessment was high. An internet-based assessment tool is likely to prove an invaluable tool in the long-term monitoring in MS.

Entities:  

Mesh:

Year:  2013        PMID: 23807152     DOI: 10.1007/s00415-013-7004-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

Review 1.  Quantification of impairment in MS: discussion of the scales in use.

Authors:  M P Amato; G Ponziani
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

2.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

3.  A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.

Authors:  J H Noseworthy; M K Vandervoort; M Hopkins; G C Ebers
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

4.  Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores.

Authors:  E M Cheng; R D Hays; L W Myers; G W Ellison; M Beckstrand; B G Vickrey
Journal:  Mult Scler       Date:  2001-12       Impact factor: 6.312

5.  Can the Expanded Disability Status Scale be assessed by telephone?

Authors:  J Lechner-Scott; L Kappos; M Hofman; C H Polman; H Ronner; X Montalban; M Tintore; M Frontoni; C Buttinelli; M P Amato; M L Bartolozzi; M Versavel; F Dahlke; J-F Kapp; R Gibberd
Journal:  Mult Scler       Date:  2003-03       Impact factor: 6.312

6.  The psychometric properties of clinical rating scales used in multiple sclerosis.

Authors:  B Sharrack; R A Hughes; S Soudain; G Dunn
Journal:  Brain       Date:  1999-01       Impact factor: 13.501

7.  Scales for rating impairment in multiple sclerosis: a critique.

Authors:  E W Willoughby; D W Paty
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition.

Authors:  J Hobart; J Freeman; A Thompson
Journal:  Brain       Date:  2000-05       Impact factor: 13.501

10.  Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years.

Authors:  Femke A H van der Linden; Jolijn J Kragt; Margarethe van Bon; Martin Klein; Alan J Thompson; Henk M van der Ploeg; Chris H Polman; Bernard M J Uitdehaag
Journal:  BMC Neurol       Date:  2008-02-28       Impact factor: 2.474

View more
  11 in total

Review 1.  An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Katherine Hope Kenyon; Frederique Boonstra; Gustavo Noffs; Helmut Butzkueven; Adam P Vogel; Scott Kolbe; Anneke van der Walt
Journal:  Cerebellum       Date:  2022-06-27       Impact factor: 3.648

2.  COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.

Authors:  Afagh Garjani; Rodden M Middleton; Rachael Hunter; Katherine A Tuite-Dalton; Alasdair Coles; Ruth Dobson; Martin Duddy; Stella Hughes; Owen R Pearson; David Rog; Emma C Tallantyre; Roshan das Nair; Richard Nicholas; Nikos Evangelou
Journal:  Mult Scler Relat Disord       Date:  2021-05-05       Impact factor: 4.808

3.  An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.

Authors:  Andrew R Romeo; William M Rowles; Erica S Schleimer; Patrick Barba; Wan-Yu Hsu; Refujia Gomez; Adam Santaniello; Chao Zhao; Jennifer R Pearce; J B Jones; Bruce C Cree; Stephen L Hauser; Jeffrey M Gelfand; Walter F Stewart; Douglas S Goodin; Riley M Bove
Journal:  Mult Scler       Date:  2020-11-25       Impact factor: 5.855

4.  Two Sides to Every Story: Perspectives from Four Patients and a Healthcare Professional on Multiple Sclerosis Disease Progression.

Authors:  Jeri Burtchell; Kristen Fetty; Katelyn Miller; Kit Minden; Daniel Kantor
Journal:  Neurol Ther       Date:  2019-07-04

5.  Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry study.

Authors:  Richard S Nicholas; Martin L Heaven; Rodden M Middleton; Manoj Chevli; Ruth Pulikottil-Jacob; Kerina H Jones; David V Ford
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-22

6.  Remote testing of vitamin D levels across the UK MS population-A case control study.

Authors:  Nicola Vickaryous; Mark Jitlal; Benjamin Meir Jacobs; Rod Middleton; Siddharthan Chandran; Niall John James MacDougall; Gavin Giovannoni; Ruth Dobson
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

7.  Defining routine fatigue care in Multiple Sclerosis in the United Kingdom: What treatments are offered and who gets them?

Authors:  Federica Picariello; Jennifer Freeman; Rona Moss-Morris
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-01-20

8.  OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis.

Authors:  Ruth Dobson; Matthew Craner; Ed Waddingham; Aleisha Miller; Ana Cavey; Stewart Webb; Cheryl Hemingway; Jeremy Hobart; Nikos Evangelou; Neil Scolding; David Rog; Richard Nicholas; Monica Marta; Camilla Blain; Carolyn Anne Young; Helen L Ford; Paul M Matthews
Journal:  BMJ Open       Date:  2021-11-25       Impact factor: 2.692

Review 9.  A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.

Authors:  Christian DE Collins; Ben Ivry; James D Bowen; Eric M Cheng; Ruth Dobson; Douglas S Goodin; Jeannette Lechner-Scott; Ludwig Kappos; Ian Galea
Journal:  Mult Scler       Date:  2015-11-12       Impact factor: 6.312

10.  The Use of Digital and Remote Communication Technologies as a Tool for Multiple Sclerosis Management: Narrative Review.

Authors:  Martin Marziniak; Giampaolo Brichetto; Peter Feys; Uta Meyding-Lamadé; Karen Vernon; Sven G Meuth
Journal:  JMIR Rehabil Assist Technol       Date:  2018-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.